← Eichor
Study identifier: NCT07312552 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Association of Periodontal Status and Smoking With Salivary Inflammasome Markers

Condition: Periodontitis · Periodontal Disease · Periodontal Health  ·  Sponsor: Uskudar University

PhaseN/A
Planned participants116
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

The aim of this study is to evaluate the relationship between periodontal status and salivary levels of the inflammasomes NOD-like receptor family, pyrin domain containing 3 (NLRP-3), NOD-like receptor family, pyrin domain containing 6 (NLRP-6), NOD-like receptor family, pyrin domain containing 12 (NLRP-12), NOD-like receptor family, CARD domain containing 5 (NLRC-5), interleukin-1 beta (IL-1β) and interleukin-10 (IL-10). Furthermore, this study aims to investigate whether the salivary levels of these inflammasomes may serve as potential diagnostic biomarkers for distinguishing individuals with periodontitis from those without. In addition, the potential role of smoking in modulating the relationship between periodontal status and salivary inflammasome levels will also be explored.

This description comes directly from the study's public registry record.

Talk to the study team

Kubra KARADURAN  ·  +905395913683  ·  kubra95krdrn@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Uskudar University, Faculty of DentistryIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07312552